Mylène Sebagh, Daniel Azoulay, Bruno Roche, Emir Hoti, Vincent Karam, Elina Teicher, Laurence Bonhomme‐Faivre, Faouzi Saliba, Jean‐Charles Duclos‐Vallée, Didier Samuel – 23 February 2011 – After liver transplantation (LT), hepatic veno‐occlusive disease (VOD), which is also known as sinusoidal obstruction syndrome (SOS), has been reported initially in relation to azathioprine use and subsequently in relation to acute rejection (AR). Isolated veno‐occlusive disease (iVOD)/SOS raises some questions about its significance and especially its treatment.

Natalie A. Molodecky, Hashim Kareemi, Rohan Parab, Herman W. Barkema, Hude Quan, Robert P. Myers, Gilaad G. Kaplan – 23 February 2011 – Incidence studies of primary sclerosing cholangitis (PSC) are important for describing the disease's burden and for shedding light on the disease's etiology. The purposes of this study were to conduct a systematic review of the incidence studies of PSC with a meta‐analysis and to investigate possible geographic variations and temporal trends in the incidence of the disease.

James R. Rodrigue, William Balistreri, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Steven J. Lobritto, Kathleen B. Schwarz, Patricia R. Robuck, Bruce Barton, Regino P. González‐Peralta – 23 February 2011 – The aim of this study was to prospectively assess the quality of life (QOL), behavioral/emotional functioning, and cognitive status of children undergoing treatment for hepatitis C virus (HCV) infection.

Wolfram Haller, Jim Buttery, Karen Laurie, Kathe Beyerle, Winita Hardikar, George Alex – 23 February 2011 – After the announcement of a worldwide pandemic in June 2009, a single dose of a monovalent pandemic H1N1 2009 influenza A (pH1N1/09) vaccine was advocated for all Australians who were 10 years and older because of excellent immunogenicity trial results for healthy children and adults. Immunocompromised patients have previously been shown to have lower seroconversion rates after routine vaccinations.

Rita Golfieri, Alberta Cappelli, Alessandro Cucchetti, Fabio Piscaglia, Maria Carpenzano, Eugenia Peri, Matteo Ravaioli, Antonia D'Errico‐Grigioni, Antonio Daniele Pinna, Luigi Bolondi – 23 February 2011 – Transarterial chemoembolization (TACE) is commonly used as a bridge therapy for patients awaiting liver transplantation (LT) and for downstaging patients initially not meeting the Milan criteria.

Melania Manco, Cristina Lo Zupone, Alessandro Latini, Vincenzina Lucidi, Lidia Monti – 23 February 2011

Rafael San‐Juan, Jose M. Aguado, Carlos Lumbreras, Jesus Fortun, Oscar Len, Patricia Munoz, Miguel Montejo, Asunción Moreno, Elisa Cordero, Marino Blanes, Antonio Ramos, Julian Torre‐Cisneros, Francisco López‐Medrano, Jordi Carratala, Enrique Moreno, for the Spanish Network of Infection in Transplantation/Spanish Network for Research in Infectious Diseases – 23 February 2011 – The role of selective intestinal decontamination with fluoroquinolones (FQ‐SID) in the prevention of early bacterial infections (EBIs) in liver transplant recipients (LTRs) is unknown.

Sven Haufe, Stefan Engeli, Petra Kast, Jana Böhnke, Wolfgang Utz, Verena Haas, Mario Hermsdorf, Anja Mähler, Susanne Wiesner, Andreas L. Birkenfeld, Henrike Sell, Christoph Otto, Heidrun Mehling, Friedrich C. Luft, Juergen Eckel, Jeanette Schulz‐Menger, Michael Boschmann, Jens Jordan – 15 February 2011 – Obesity‐related hepatic steatosis is a major risk factor for metabolic and cardiovascular disease. Fat reduced hypocaloric diets are able to relieve the liver from ectopically stored lipids.

Robert J. Clifford, Kenneth H. Buetow – 15 February 2011

Amar Deep Sharma, Nidhi Narain, Eva‐Maria Händel, Marcus Iken, Nishant Singhal, Toni Cathomen, Michael P. Manns, Hans R. Schöler, Michael Ott, Tobias Cantz – 15 February 2011 – Death receptor‐mediated apoptosis of hepatocytes contributes to hepatitis and fulminant liver failure. MicroRNAs (miRNAs), 19‐25 nucleotide‐long noncoding RNAs, have been implicated in the posttranscriptional regulation of the various apoptotic pathways. Here we report that global loss of miRNAs in hepatic cells leads to increased cell death in a model of FAS/CD95 receptor‐induced apoptosis.